Sherbrooke Park Advisers’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$235K Buy
28,639
+4,234
+17% +$34.8K 0.1% 355
2025
Q1
$174K Buy
24,405
+75
+0.3% +$536 0.08% 447
2024
Q4
$188K Sell
24,330
-5,377
-18% -$41.6K 0.06% 600
2024
Q3
$312K Buy
29,707
+13,850
+87% +$145K 0.07% 549
2024
Q2
$186K Buy
+15,857
New +$186K 0.03% 780